Rational Design of Targeted Next-Generation Carriers for Drug and Vaccine Delivery
- 11 July 2016
- journal article
- review article
- Published by Annual Reviews in Annual Review of Biomedical Engineering
- Vol. 18 (1) , 25-49
Abstract
Pattern recognition receptors on innate immune cells play an important role in guiding how cells interact with the rest of the organism and in determining the direction of the downstream immune response. Recent advances have elucidated the structure and function of these receptors, providing new opportunities for developing targeted drugs and vaccines to treat infections, cancers, and neurological disorders. C-type lectin receptors, Toll-like receptors, and folate receptors have attracted interest for their ability to endocytose their ligands or initiate signaling pathways that influence the immune response. Several novel technologies are being developed to engage these receptors, including recombinant antibodies, adoptive immunotherapy, and chemically modified antigens and drug delivery vehicles. These active targeting technologies will help address current challenges facing drug and vaccine delivery and lead to new tools to treat human diseases. Expected final online publication date for the Annual Revi...Keywords
This publication has 152 references indexed in Scilit:
- Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid ProteinMolecular Pharmaceutics, 2012
- Responsive Theranostic Systems: Integration of Diagnostic Imaging Agents and Responsive Controlled Release Drug Delivery CarriersAccounts of Chemical Research, 2011
- Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticlesBiomaterials, 2011
- Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9AProceedings of the National Academy of Sciences, 2011
- Targeted Imaging and Therapy of Brain Cancer Using Theranostic NanoparticlesMolecular Pharmaceutics, 2010
- Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccineVaccine, 2010
- Ultrasmall Near‐Infrared Non‐cadmium Quantum Dots for in vivo Tumor ImagingSmall, 2010
- In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responsesNature Biotechnology, 2009
- Carbohydrate‐Mediated Targeting of Antigen to Dendritic Cells Leads to Enhanced Presentation of Antigen to T CellsChemBioChem, 2008
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007